Alzamend Neuro (ALZN) Earnings Analysis

Alzamend Neuro (ALZN) next reports earnings on 2026-09-09, consensus EPS -0.67 USD. Last quarter (2026-07-22) it missed with EPS -0.74 USD vs -0.67 USD est (-10.4%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -0.29.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ALZN next report earnings?

Next earnings date2026-09-09
Consensus EPS estimate-0.67 USD
Revenue estimaten/a

ALZN earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-22-0.74 USD-0.67 USD-10.4%Miss
2026-03-11-0.58 USD-0.53 USD-9.4%Miss
2025-12-09-0.3 USD-0.83 USD+63.9%Beat
2025-09-10-1.28 USD-3.69 USD+65.3%Beat
2025-03-10-1.71 USD-2.61 USD+34.5%Beat
2024-12-11-3.6 USD-21.42 USD+83.2%Beat
2024-09-11-11.25 USD-2.38 USD-372.7%Miss

Beat rate: 4/7 (57%) over reported quarters with consensus data.

ALZN valuation and analyst view

Trailing P/E-0.29
Trailing EPS-1.85082 USD
Price / book7.01
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Alzamend Neuro (ALZN)'s next earnings date?

Alzamend Neuro is next scheduled to report on 2026-09-09, with a consensus EPS estimate of -0.67 USD.

Did ALZN beat earnings last quarter?

In its 2026-07-22 report, ALZN posted EPS of -0.74 USD versus a -0.67 USD estimate — a miss of 10.4%.

What is ALZN's earnings track record?

Over the last 7 reported quarters with consensus data, ALZN beat estimates 4 times (57%).

What is ALZN's current P/E ratio and EPS?

ALZN trades at a trailing P/E of -0.29 on trailing EPS of -1.8508166521715932 USD.

What do analysts rate ALZN?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).